NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ReVision Implant

ReVision Implant

Private
BelgiumHealthcare & Life Scienceshttps://www.revision-implant.com/

Last Round

Seed

May 26, 2026

Total Funding Raised

$7.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ReVision Implant is a neurotechnology company developing a cortical visual prosthesis to restore functional vision in people with severe blindness by transmitting video directly to the brain's visual cortex.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

cortical visual prosthesisBCIbrain-computer interfacebionic eyevision restorationbrain implantneurotechnologyvisual neuroprosthesisneurostimulationmedical deviceblindness treatmentvisual cortex stimulationmicro-electrode arrayFDA Breakthrough Deviceclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ReVision Implant Comps

Public and private peers based on sector, stage, and business model.

ReVision Implant comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ReVision Implant Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 26, 2026
GrantJan 11, 2025

Key People

Founding team and executive leadership

Frederik Ceyssens

Founder CEO

Founding Team

Maarten Schelles

CTO

Executive Team

ReVision Implant Investors

Notable investors and investment history

ReVision Implant investors
InvestorRounds
European Innovation CouncilGrant
Plug and Play Tech CenterSeed
imec.istartSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    $4.65M raised in early funding.

  • Feb 16, 2026

    Grew 67% QoQ, from 6 to 10 employees.

ReVision Implant Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ReVision Implant Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ReVision Implant's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range10
Year Founded2020
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.